Li Yinglan, Guan Qingran, Xu Jie, Zhang Huaizhen, Liu Sisi, Ding Zhuang, Wang Qingpeng, Wang Zhengping, Liu Min, Zhao Yanna
Institute of Biopharmaceutical Research, Liaocheng University, Liaocheng, Shandong 252059, People's Republic of China.
School of Geography and Environment, Liaocheng University, Liaocheng, Shandong 252059, People's Republic of China.
Colloids Surf B Biointerfaces. 2023 May;225:113267. doi: 10.1016/j.colsurfb.2023.113267. Epub 2023 Mar 14.
Herein, cyclosporine A loaded liposomes (CsA-Lips) were fabricated aimed at improving the biocompatibility of the ophthalmic formulation and getting rid of the direct contact of ocular tissues with irritant excipients. Response surface methodology was exploited in order to investigate the influence of miscellaneous factors on the key characteristics of CsA-Lips. Ratio of EPC:CsA, ratio of EPC:Chol, and stirring speed were selected as the independent variables, while size, drug-loading content (DL), and drug-loading content (DL) loss rate were applied as the response variables. In case of the maximal lack-of-fit p-value and minimum sequential p-value, quadratic model was regarded as the fittest model to analyze the data. The correlation of independent variables with response variables was described by three-dimension surface figures. Optimized formulation for CsA-Lips was obtained with ratio of EPC:CsA set as 15, ratio of EPC:Chol set as 2, and stirring speed set as 800 rpm. The particle size of CsA-Lips was 129.2 nm after optimalization while their TEM images exhibited spherical unilamellar vesicles with clearly shell-core structure. CsA released more rapidly from CsA-Lips in comparison with self-made emulsion and Restasis®. Besides, minimum cytotoxicity of CsA-Lips was perceived via both MTT method and LDH method, indicating the excellent compatibility of the ophthalmic formulation. Simultaneously, CsA-Lips showed enhanced nonspecific internalization in the cytoplasm with a time-dose-dependent manner. In conclusion, CsA-Lips could be adhibited as the hopeful ophthalmic drug delivery system clinically for dry eye syndrome (DES).
在此,制备了载环孢素A脂质体(CsA-Lips),旨在提高眼科制剂的生物相容性,并避免眼组织与刺激性辅料直接接触。采用响应面法研究各种因素对CsA-Lips关键特性的影响。选择EPC:CsA比例、EPC:Chol比例和搅拌速度作为自变量,同时将粒径、载药量(DL)和载药量损失率作为响应变量。在失拟p值最大和顺序p值最小的情况下,二次模型被认为是分析数据的最合适模型。通过三维表面图描述自变量与响应变量之间的相关性。获得了CsA-Lips的优化配方,EPC:CsA比例设定为15,EPC:Chol比例设定为2,搅拌速度设定为800 rpm。优化后CsA-Lips的粒径为129.2 nm,其透射电镜图像显示为具有清晰核壳结构的球形单层囊泡。与自制乳剂和Restasis®相比,CsA从CsA-Lips中释放得更快。此外,通过MTT法和LDH法均观察到CsA-Lips的细胞毒性最小,表明该眼科制剂具有优异的相容性。同时,CsA-Lips在细胞质中的非特异性内化增强,呈时间-剂量依赖性。总之,CsA-Lips有望作为临床治疗干眼症(DES)的眼科药物递送系统。